Drug name - Zimhi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11027072 ADAMIS PHARMS CORP Emergency devices
May, 2039

(16 years from now)

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 15 October, 2021

Treatment: NA

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
5MG/0.5ML (5MG/0.5ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in